INTRODUCTION
============

Eukaryotic gene expression produces large amounts of both protein-coding and non-coding RNA species. To ensure proper cellular function and viability, a high level of fidelity must be sustained. To tackle this challenge, RNA surveillance and decay serve three main purposes: first, to ensure RNA quality control (RQC) mechanisms that scrutinize RNA integrity and eliminate defective messenger RNA (mRNA), thus dampening the production of potentially toxic proteins, second, to regulate mRNA turnover to control protein abundance and third, to detect invading RNAs, to defend the cell against them ([@gkt152-B1; @gkt152-B2; @gkt152-B3; @gkt152-B4]) and to regulate selected endogenous mRNAs through an endonucleolytic cleavage process called post-transcriptional gene silencing (PTGS) ([@gkt152-B5; @gkt152-B6; @gkt152-B7; @gkt152-B8]). How RQC and PTGS pathways interact and the processes that regulate the partitioning of RNA substrates into these pathways are not well understood.

Nonsense-mediated decay (NMD) is an extensively studied RQC pathway involved in the genome-wide suppression of transcripts ([@gkt152-B9; @gkt152-B10; @gkt152-B11]) in which translation is arrested either owing to the presence of a premature termination codon or owing to excessive 3′untranslated region (UTR) length ([@gkt152-B12; @gkt152-B13; @gkt152-B14; @gkt152-B15; @gkt152-B16]). Although there are several different mechanisms by which NMD can be triggered, once instigated, NMD generally involves the recruitment and activation of conserved UPFRAMESHIFT 1 (UPF1), UPF2 and UPF3 proteins to defective transcripts that are translationally stalled. However, the presence of an exon junction complex (EJC) is not always required to evoke NMD because it can target intronless transcripts in yeast, mammals, flies and plants ([@gkt152-B17; @gkt152-B18; @gkt152-B19; @gkt152-B20; @gkt152-B21]). This recruitment, either by invoking decapping and deadenylation pathways or via endonucleolytic cleavage, as is the case in *Drosophila* and humans, generates aberrant RNAs \[RNAs lacking a 5′-cap structure or a 3′-poly(A) tail\] that are subsequently degraded through exonucleolytic cleavage \[for reviews see ([@gkt152-B2],[@gkt152-B22],[@gkt152-B23])\].

Exonucleolytic RNA degradation in *Arabidopsis* exploits a suite of processes including, but not limited to, the shortening of the 3′-poly(A) tail (deadenylation), which is catalysed by the conserved 3′--5′ POLY(A)-SPECIFIC RIBONUCLEASE (PARN) as well as by the conserved CARBON CATABOLITE REPRESSOR 4 (CCR4) complex ([@gkt152-B24; @gkt152-B25; @gkt152-B26; @gkt152-B27]). It also involves the removal of the 5′-cap structure, which is accomplished by a set of conserved decapping proteins: DCP1, DCP2 (TDT), DCP5, VARICOSE (VCS) and possibly DEA(D/H)-box RNA HELICASE 1 (DHH1) ([@gkt152-B28; @gkt152-B29; @gkt152-B30]). Decapping and deadenylation are a prerequisite for most RNA to be degraded by 5′--3′ XRN exoribonucleases and the multimeric 3′--5′ exoribonuclease exosome complex. *Arabidopsis* expresses three XRN proteins, the nuclear XRN2 and XRN3 and the cytoplasmic XRN4 ([@gkt152-B31]). Biochemical and molecular characterization of the *Arabidopsis* exosome core complex revealed the subunits RRP4, RRP40, RRP41, RRP42, RRP43, RRP45 (CER7), RRP46, CSL4 and MTR3 ([@gkt152-B32]). Additional components likely involved in exosome function include RRP44, RRP6L1, RRP6L2, RRP6L3 and MTR4 ([@gkt152-B32; @gkt152-B33; @gkt152-B34; @gkt152-B35]).

In addition to these RNA degradation mechanisms, plants and other eukaryotes use PTGS to defend against foreign invading RNAs, such as viruses and high levels of transgenic mRNAs ([@gkt152-B36; @gkt152-B37; @gkt152-B38; @gkt152-B39; @gkt152-B40]). PTGS also is required to modulate the abundance or expression of cellular mRNAs important during developmental transitions, such as the mRNAs targets of the trans-acting small interfering (ta-si)RNA pathway ([@gkt152-B41],[@gkt152-B42]). Double-stranded (ds)RNA is the priming trigger of PTGS and is generated though several processes such as viral replication, sense-antisense transcription or transcription of inverted-repeat (IR) sequences, whose transcripts are self-complementary and thus fold-back on themselves to form dsRNA. It can also be produced by the cellular RNA-DEPENDENT RNA POLYMERASE 6 (RDR6/SGS2/SDE1), which is coupled to the RNA stabilizing protein SUPPRESSOR OF GENE SILENCING 3 (SGS3). Once the dsRNA is produced, it is processed by DICER-LIKE (DCL) enzymes into 21--22-nt siRNAs, which serve as sequence-specific guides for ARGONAUTE 1 (AGO1)-dependent endonucleolytic cleavage of complementary transcripts ([@gkt152-B6],[@gkt152-B43],[@gkt152-B44]). AGO1-mediated cleavage generates RNAs that are, in most cases, subjected to XRN- and exosome-mediated degradation ([@gkt152-B45]). In the case of viruses, once PTGS is instigated, amplification of the siRNAs ensures that tissues are primed against subsequent infection by the same virus or expression of a transgene bearing virus sequences ([@gkt152-B46],[@gkt152-B47]).

Previous data suggested that defects in RNA processing and degradation that lead to the accumulation of decapped and deadenylated RNA, including mutations in RNA splicing, 3′-end formation and 5′--3′ exoribonuclease XRN-mediated degradation, promote PTGS ([@gkt152-B48; @gkt152-B49; @gkt152-B50]). Moreover, removing transgene 3′-terminator sequences enhanced PTGS, while having multiple terminators reduced PTGS ([@gkt152-B51]). Here, we explore the ways in which an array of nuclear and cytoplasmic RQC factors and PTGS interact mechanistically and spatially in plants. Impairing either nuclear or cytoplasmic NMD UPF1 and UPF3, deadenylation PARN and CCR4a and exosome RRP4, RRP6L1, RRP41 and RRP44A components enhanced sense (S)-PTGS but had no effect on an IR-PTGS system. In the cytoplasm, RQC factors localized in siRNA-body and processing (P)-body RNA degradation foci. These findings show that nuclear and cytoplasmic aberrant RNAs are instrumental during this type of RNA silencing process, as opposed to IR-PTGS, which produces dsRNA, a direct template for the DCLs. The correct partitioning of aberrant RNA substrates among these RNA degradation mechanisms ensures the discrimination of dysfunctional self-RNA and invading non--self-RNA from functional self-RNA and acts as a barrier to prevent the undesired triggering of PTGS of self-RNA.

MATERIALS AND METHODS
=====================

Plant material
--------------

All *Arabidopsis thaliana* are in the Columbia accession ([@gkt152-B52]). The *JAP3* line was the kind gift of D. Baulcombe and the inducible RNA interference (iRNAi) lines *rrp41^iRNAi^* and *rrp4^iRNAi^* ([@gkt152-B32]) were the kind gift of J. Ecker. The parn \[fast neutron mutant *ahg2-1*; ([@gkt152-B53])\] was kindly provided by T. Hirayama. The *upf1-5* (*SALK_112922*, insertion located in the 3′UTR) was obtained from NASC. Homozygous *ccr4a* (*SAIL_784_A07*, insertion located in intron 9/10), *ccr4b* (*SAIL_635_B07*, insertion located in exon 2/11), *upf1-6* (*SAIL_1295_E07*, insertion located 148 bp upstream of the ATG), *upf3-3* (*SAIL_122_G02*, insertion located 183 bp upstream of the ATG), *upf3-1* (*SALK_025175*, insertion located in exon 5/12) and *rrp6L1* (*rrp6A*; *SAIL_1306_C10* insertion located in intron 12/13) mutants were generated during this study (see [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1) for molecular characterization). Seeds were obtained from NASC.

Generation of artificial miRNA lines
------------------------------------

The artificial miRNA *amiR-RRP44Aa* (5′-UAUGAGUAUACAGGCGUGCUG-3′) was generated using the WMD3 microRNA designer (<http://wmd3.weigelworld.org/cgi-bin/webapp.cgi>) and expressed under the ubiquitin promoter in the context of the *MIR319a* backbone. PTGS reporter lines were transformed using the floral dip methods ([@gkt152-B54]) and transformed plants were selected on 15 μg/ml of glufosinate. PTGS was analysed in the progeny of 3 T2 lines harbouring a single *UB::amiR-RRP44a* insertion.

RNA extraction and RNA gel blot analysis
----------------------------------------

For RNA gel blot analyses, frozen tissue was homogenized in a buffer containing 0.1 M NaCl, 2% sodium dodecyl sulphate (SDS), 50 mM Tris--HCl (pH 9.0), 10 mM ethylenediaminetetraacetic acid (pH 8.0) and 20 mM β-mercaptoethanol, and RNAs were extracted two times with phenol and recovered by ethanol precipitation. To obtain high molecular weight (HMW) RNA, total RNA was precipitated overnight in 2 M LiCl at 4°C and recovered by centrifugation. For low molecular weight (LMW) RNA analysis, total RNA was separated on a 15% denaturing polyacrylamide gel electrophoresis gel, stained with ethidium bromide and transferred to nylon membrane (HybondNX, Amersham). LMW RNA and *U6* hybridizations were at 50°C with hybridization buffer containing 5× saline-sodium citrate (SSC), 20 mM Na~2~HPO~4~, pH 7.2, 7% SDS, 2× Denhardt's solution and denatured sheared salmon sperm DNA (Invitrogen). HMW RNA hybridization was at 37°C in SigmaPerfectHyb buffer (Sigma). Blots were hybridized with a radioactively labelled random-primed DNA probes for beta-glucuronidase (*GUS*) mRNA and *GUS* siRNAs, and end-labelled oligonucleotide probes for *TAS1* ta-sRNA, *TAS2* tasRNA and *U6* detection.

GUS activity quantification
---------------------------

With the exception of *amiR-RRP44A*, *rrp41^iRNAi^* and *rrp4^iRNAi^* lines, plants were grown on Bouturage 2 medium (Duchefa Biochemie) in standard long-day conditions (16 h light, 8 h dark at 20--22°C), transferred to soil after 2 weeks and grown in controlled growth chambers in standard long-day conditions. To induce expression of the RNAi lines, *rrp41^iRNAi^* and *rrp4^iRNAi^* plants were grown on Bouturage media containing 8 μM estradiol for 12 days in standard long-day conditions, and then transferred to soil and grown in controlled growth chambers in standard long-day conditions. Total protein was extracted from cauline leaves of flowering plants and GUS activity was quantified as in ([@gkt152-B49]) by measuring (Fluoroscan II; Thermo Scientific) the quantity of 4-methylumbelliferone produced from the substrate 4-methylumbelliferyl-b-[d]{.smallcaps}-glucuronide (Duchefa Biochemie).

Semi-quantitative reverse transcriptase-polymerase chain reaction
-----------------------------------------------------------------

RNAs were extracted using the RNeasy plant mini kit (Qiagen), and 1 μg of RNA was reverse transcribed using oligo dT and Super ScriptII reverse transcriptase (Invitrogen). Twenty-seven cycles of polymerase chain reaction (PCR) were used to amplify *RRP44A*, *CCR4a*, *CCR4b* and *EF1-alpha*, and 28 cycles of PCR were used to amplify *UPF1* and *UPF3* to non-saturation. The number of cycles used to amplify *RRP4* and *RRP6L1* to non-saturation is indicated above each lane in [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1). *EF1-alpha* amplification was used as a control.

*Nicotiana benthamiana* agro-infiltration
-----------------------------------------

Agrobacterium (ASE or Agl0 strains) carrying plasmids of interest were grown overnight at 30°C in 3 ml Lysogeny Broth (LB) medium containing the appropriate antibiotics to a final OD600 of between 1.0 and 2.0. The bacteria were pelleted and resuspended in 1 ml of infiltration medium (10 mM MgCl~2~, 10 mM 2-(N-morpholino)ethanesulfonic acid (MES), pH 5.2, 150 mM acetosyringone) to a final OD600 of 0.1. The bacterial solution containing the plasmid(s) of interest was coinfiltrated with a bacterial solution expressing HELPER COMPONENT-PROTEINASE (HC-Pro), a viral suppressor of silencing, into the abaxial side of leaves using a 1 ml syringe, and samples were assayed 3 days after infiltration. HC-Pro was used to better visualize the fluorescent signals and did not have an observable impact on the localization pattern of the tested RQC and PTGS components.

Confocal imaging
----------------

For confocal imaging, agro-infiltrated tobacco leaves (mounted in water) were directly imaged on a Leica Confocal TCS SP2 (Leica Microsystems). The CFP was imaged with 458 nm excitation using the dichroic mirror DD458/514 and detection window of 465--505 nm; the GFP was imaged with 488 nm excitation using the dichroic mirror DD488/543 and a detection window of 500--580 nm; the RFP was imaged with 543 nm excitation using the dichroic mirror DD488/543 and a detection window of 580--670 nm. For the co-localizations, all of the images were taken by sequential acquisition. Image analysis was performed using the National Institute of Health ImageJ (<http://rsb.info.nih.gov/ij/>) software.

Cloning procedures
------------------

All the clones were made using the Gateway technology (Invitrogen) and planned using Geneious (<http://www.geneious.com>). A list of the oligonucleotides used for cloning is provided in [Supplementary Table S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1). *UPF3* (*AT1G33980*), *SGS3* (*AT5G23570*) and *RRP41* (*AT3G61620*) were PCR amplified from complementary DNA (cDNA) and cloned into the vector *pDONR221* to generate entry clones, whereas *PARN* (*AT1G55870*), *CCR4a* (*AT3G58560*) and *RRP4* (*AT1G03360*) were PCR amplified from genomic DNA and cloned into the vector *pENTR-D* to generate entry clones. To obtain the GFP fusions under the control of the *35S* promoter, *SGS3*, *CCR4a*, *PARN* and *RRP41* entry clones were recombined in the expression vector *pH7WGF2*, whereas the *UPF3* entry clone was recombined in the expression vector *pH7FWG2*. To obtain the RFP fusion proteins under the control of the *35S* promoter, the entry clone containing *PARN* was recombined in the expression vector *pB7WGR2*, and the one containing *RRP4* in the expression vector *pB7RWG2*. For the GFP fusion under the control of the *Ubiquitin10* promoter, the *RRP4* entry clone was recombined in the expression vector *pUBN-GFP* ([@gkt152-B55]). The *35S:RFP:DCP1* and *35S:CFP:DCP1* constructs were made by recombination of an entry clone containing *DCP1* (*AT1G08370*, gift from C. Antonelli) in the expression vectors *pB7WGR2* and *pB7WGC2*, respectively ([@gkt152-B56]). The *35S:RDR6:GFP* construct was made by PCR amplifying *RDR6* (*AT3G49500*) from cDNA and adding the restriction sites SalI and NotI to each terminus to generate a Gateway entry clone in the plasmid *pENTR1A* that was then recombined in the expression vector *pH7FWG2*. The construct *pGFP-N-Bin:UPF1* (*AT5g47010*) was generously provided by A. Pendle and J. Brown. The construct *35S:RFP:UPF1* was obtained by recombining the entry clone *UPF1* cDNA *pDONR207* (kindly provided by A. Pendle and J. Brown) into the expression vector *pB7WGR2*. The *35S::HC-Pro* plasmid was the kind gift of J. Carrington.

RESULTS
=======

To investigate the possible crosstalk between PTGS and other RNA degradation pathways, we isolated loss-of-function *Arabidopsis* mutants in many key components of RQC and RNA turnover pathways and characterized their impact on S-PTGS. In the cases where loss-of-function caused lethality, we examined the impact of partial-loss-of-function mutants when possible. The effect of RQC and RNA turnover mutants on S-PTGS was determined using the well-characterized *Arabidopsis* reporter lines *Hc1* and *6b4*. Both lines carry a *35S::GUS* transgene, but whereas 6b4 stably produces GUS, silencing of the *GUS* transgene is spontaneously triggered in 20% of *Hc1* plants at each generation add ([@gkt152-B57],[@gkt152-B58]). These reporter systems allowed us to reveal both positive and negative effects of the RQC mutations on S-PTGS. To avoid the *35S* interference phenomenon reported to occur when introducing the *35S::GUS* transgene carried by the *6b4* and *Hc1* into mutants already carrying a *35S* T-DNA insertion ([@gkt152-B59]), we analysed S-PTGS uniquely in mutants containing either *35S*-free T-DNA insertions or fast neutron-generated mutations.

Mutations in NMD, deadenylation and exosome factors enhance S-PTGS
------------------------------------------------------------------

To examine the contribution of NMD to PTGS, we searched publicly available mutant collections and identified *upf1* (*SAIL_1295_E07*, hereafter referred to as *upf1-6*), and *upf3* (*SAIL_122_G02*, hereafter referred to as *upf3-3*) partial-loss-of-function mutants ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)A), and these mutants were crossed with *Hc1* and *6b4* lines. Quantitative GUS assays performed on the progeny of plants homozygous for both the *Hc1* locus and either the *upf1* or *upf3* mutation indicated that *Hc1* silencing was enhanced from 20% in line *Hc1* to 44% in *Hc1/upf1-6* and to 78% in *Hc1/upf3-3* ([Figure 1](#gkt152-F1){ref-type="fig"}A). To determine the strength of the silencing enhancement, we also analysed the effect of these mutations on line *6b4*. The *upf3-3* mutation triggered silencing in 13% of the *6b4* plants analysed ([Figure 1](#gkt152-F1){ref-type="fig"}B), whereas *upf1-6* did not appear to have an effect on *6b4* silencing (0/32 plants were silenced at the *6b4* locus). Characteristic of PTGS, *GUS* siRNAs accumulated and *GUS* mRNA levels were reduced to nearly undetectable levels in the silenced *Hc1*/*upf1-6*, *Hc1*/*upf3-3* and *6b4*/*upf3-3* lines ([Figure 1](#gkt152-F1){ref-type="fig"}C and D), indicating that both UPF1 and UPF3 are endogenous PTGS suppressors. Figure 1.NMD, deadenylation and exosome mutants enhance transgene S-PTGS. (**A** and **B**) The percentage of silenced plants determined by GUS quantitative protein assays in the indicated mutant and control lines. The number of plants analysed is indicated above each bar. (**C** and **D**) RNA gel blot analyses of the indicated mutant and control lines. High molecular weight RNA and siRNA gel blots were hybridized with a *GUS* DNA probe. *25S* ribosomal RNA (rRNA) and *U6* small nucleolar RNA (snRNA) served as loading controls, respectively. *Hc1* plants that were expressing (+) and silenced (−) for *GUS* were analysed. The position of *GUS* 24, 22 and 21 nt siRNAs is noted. Normalized values of *GUS* mRNA to *25S* rRNA (with either *Hc1* (+) or *6b4* levels set at 1.0) and *GUS* 24 nt and *GUS* 21--22 nt siRNA to *U6* snRNA \[with *Hc1* (−) levels set at 1.0\] are indicated. ND = non-detectable.

*Arabidopsis* PARN has poly(A) RNA degradation activity and complete loss-of-function parn mutants are lethal, indicating that it is an essential ribonuclease ([@gkt152-B13]). Nevertheless, a fast neutron-generated partial-loss-of-function alternative splicing parn mutant ahg2-1 has been described ([@gkt152-B60]). Quantitative GUS assays on plants homozygous for both the *Hc1* transgene and the *ahg2-1* (*parn*) mutation indicated that silencing of *Hc1* was increased from 20% to nearly 50% ([Figure 1](#gkt152-F1){ref-type="fig"}A). In addition, *ahg2-1* triggered silencing in nearly 40% of *6b4* plants ([Figure 1](#gkt152-F1){ref-type="fig"}B), indicating that PARN is a suppressor of PTGS. Like the *parn* mutant that negatively impacts deadenylation, a mutation in the putative deadenylation factor CCR4a enhanced *Hc1* silencing from 20% to nearly 60% ([Figure 1](#gkt152-F1){ref-type="fig"}A); however, unlike the *parn* mutant, the *ccr4a* mutation did not trigger silencing of line *6b4* (0/30 of *6b4*/*ccr4a* plants were silenced). Silencing triggered by both *parn* and *ccr4a* deadenylation mutants led to the accumulation of *GUS* siRNAs and a reduction in *GUS* mRNA levels ([Figure 1](#gkt152-F1){ref-type="fig"}C and D). In contrast to *ccr4a*, a mutation in the related *CCR4b* gene, which is located adjacent to the *CCR4a* gene, did not impact *Hc1* or *6b4* silencing (18%, 10/56 *Hc1/ccr4b* plants and 0%, 0/39 *6b4/ccr4b* plants were silenced), suggesting that CCR4b could be partially redundant with CCR4a. Both *ccr4a* and *ccr4b* mutants appeared to be full-loss-of-function mutants, as they did not produce detectable *CCR4a* and *CCR4b* transcripts, respectively ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)B), but additional work will be required to determine whether these proteins are partially redundant.

The multimeric exosome complex contains 3′--5′ exoribonucleases that degrade RNA with unprotected 3′-ends. To determine if perturbations in exosome function could influence PTGS, we characterized the impact on S-PTGS in the *Hc1* and *6b4* reporter lines of mutants defective in the *Arabidopsis* core exosome subunits RRP4 and RRP41, the latter of which exhibits catalytic 3′--5′ RNAse activity, unlike the yeast and human RRP41 ([@gkt152-B61]). We also examined the impact on S-PTGS of impairing RRP44A, the *Arabidopsis* homolog of the RRP44 (DIS3) 3′--5′ RNAse responsible for nearly all of the catalytic activity of the yeast exosome ([@gkt152-B62],[@gkt152-B63]). Finally, we examined the impact on S-PTGS of a mutation in RRP6L1 \[also known as RRP6A; [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)C ([@gkt152-B32],[@gkt152-B64])\], one of two *Arabidopsis* homologs of the yeast and human RRP6 exoribonuclease. Although the nuclease function of *Arabidopsis* RRP6L1 has not been confirmed, expression of *Arabidopsis RRP6L1* complements the growth defects of a yeast *rrp6* mutant strain ([@gkt152-B64]). Because *rrp4* and *rrp41* mutants are seedling lethal, we analysed PTGS in the previously characterized *rrp4* and *rrp41* iRNAi lines, which silence *RRP4* and *RRP41* after estradiol treatment owing to the induced expression of an IR transgene targeting *RRP4* and *RRP41*, respectively \[[Supplementary Figure S1D](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1) and ([@gkt152-B32])\]. Furthermore, because *35S*-free loss-of-function mutants in *rrp44A* were not available, we generated *Arabidopsis* lines expressing an artificial miRNA ([@gkt152-B65]) (*amiR-RRP44A*) under the ubiquitin promoter, and analysed PTGS in line *Hc1*.

Quantitative GUS assays indicated that loss-of-function of *rrp6L1* and down-regulation of *rrp4^iRNAi^* and *rrp41^iRNAi^* enhanced PTGS in line *Hc1* from the 20% baseline to 30, 90 and 80%, respectively ([Figure 1](#gkt152-F1){ref-type="fig"}A). Furthermore, analysis of S-PTGS in *Hc1/amiR-RRP44A* plants revealed that line 46, which accumulated more *amiR-RRP44A* ([Figure 2](#gkt152-F2){ref-type="fig"}A) and less *RRP44A* mRNA ([Figure 2](#gkt152-F2){ref-type="fig"}B) than lines 43 and 53, triggered PTGS in 100% of *Hc1* plants analysed ([Figure 2](#gkt152-F2){ref-type="fig"}C) and accumulated *GUS* siRNAs ([Figure 2](#gkt152-F2){ref-type="fig"}B). Moreover, the *rrp4^iRNAi^* and *rrp41^iRNAi^* lines triggered PTGS in nearly 70 and 100% of *6b4* plants, respectively ([Figure 1](#gkt152-F1){ref-type="fig"}B), whereas *rrp6L1* mutants did not trigger silencing of *6b4* (*GUS* silencing was not observed in 64 *6b4/rrp6L1* plants). The effect of the expression of the artificial *amiR-RRP44A* on *6b4* PTGS was not tested. Collectively these data indicate that mutations in a variety of components involved in RQC and exonucleolytic RNA turnover have the capacity to enhance S-PTGS. As all these pathways act on single-stranded (ss)RNA, these results suggest that modulation of ssRNA abundance is a key element controlling entry into PTGS. Figure 2.Expression of an artificial miRNA targeting *RRP44A* leads to enhanced S-PTGS. (**A**) RNA gel blot analyses of three different *Hc1* plant lines expressing the artificial *RRP44A* miRNA *amiR-RRP44A*. Small RNA gel blots were hybridized with a *GUS* DNA probe or an oligonucleotide antisense to the amiR. *U6* served as a loading control for small RNA. (**B**) Reverse transcriptase-PCR of *RRP44A* and *RRP44B* transcripts in the corresponding *Hc1/amiR*-RRP44A and control *Hc1* seedlings. *EF1alpha* was used as an amplification control. Normalized values of *RRP44A* and *RRP44B* mRNA to *EF1 alpha* mRNA (with *Hc1* levels set at 1.0) are indicated. (**C**) The percentage of silenced plants determined by GUS quantitative protein assays in the indicated mutant and control lines. The number of plants analysed is indicated above each bar.

To broaden our S-PTGS analysis to an endogenous silencing system that, like S-PTGS, requires RDR6 and SGS3 for dsRNA production, we examined the effect of RQC mutants on the ta-siRNA pathway ([@gkt152-B66; @gkt152-B67; @gkt152-B68; @gkt152-B69]). We did not observe any changes in tasiRNA levels arising from the *TAS1* or *TAS2* locus in any of our RQC mutants ([Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)).

Mutations in NMD, deadenylation and exosome components do not impact IR-PTGS
----------------------------------------------------------------------------

Next, we examined the impact of mutations in these NMD, deadenylation and exosome components on a PTGS system that produces a stem-loop dsRNA directly through transcription and, thus, does not rely on the RDR6- and SGS3-dependent conversion of ssRNA to dsRNA to become a substrate of DCL proteins. The line *JAP3* expresses a *PHYTOENE DESATURASE (PDS)* inverted repeat under the control of the phloem-specific *Suc2* promoter ([@gkt152-B70]) and initiates from the veins PDS silencing, which can be easily traced owing to the photobleaching phenotype.

Mutations in NMD, deadenylation and the core exosome complex did not appear to impact the initiation or spreading of IR-PTGS in the line *JAP3* ([Figure 3](#gkt152-F3){ref-type="fig"}). It was shown previously that UPF1 influenced RNAi persistence in *Caenorhabditis elegans* and IR-PTGS in *Arabidopsis*, but UPF1 did not appear to affect RNAi in Drosophila ([@gkt152-B71; @gkt152-B72; @gkt152-B73]). The analysis in *Arabidopsis* examined the effect of the *upf1-5* mutant, a SALK T-DNA insertion line containing a *35S* promoter, on an IR of the endogenous *APETALA 3* (*AP3*) gene that was expressed under the *35S* promoter ([@gkt152-B71]). Given the report of *35S* interference on PTGS observed when combining two transgenes each containing the *35S* promoter ([@gkt152-B59]), we re-examined the effect of the *upf1-5* mutant on IR-PTGS using the *JAP3 35S*-free IR-PTGS system. Similar to what we observed for the *upf1-6* mutant, the *upf1-5* mutant did not appear to impact the initiation or spreading of *JAP3* IR-PTGS ([Figure 3](#gkt152-F3){ref-type="fig"}), indicating that UPF1 likely does not play a role in IR-PTGS in *Arabidopsis* and that the initial report likely was hampered by *35S* interference. Figure 3.NMD, deadenylation and exosome mutants do not impact *JAP3* IR-PTGS. Eighteen-day-old control *JAP3* plants and *JAP3* plants containing the indicated mutations. The photo is representative of a minimum of 20 plants screened for each genotype.

These results indicate that deadenylation, NMD and exosome components impinge on PTGS at a step unique to S-PTGS that is not required for IR-PTGS. It is interesting to speculate that this step is linked to aberrant ssRNA protection or dsRNA generation, processes accomplished by the SGS3 and RDR6 proteins, respectively ([@gkt152-B74; @gkt152-B75; @gkt152-B76]).

Both nuclear and cytoplasmic RNA decay proteins regulate S-PTGS
---------------------------------------------------------------

To determine where within the cell the different exonucleolytic RNA decay and S-PTGS pathways could overlap, we first expressed a subset of the components for which mutations were shown to alter S-PTGS as translational fusions to fluorescent reporters in *N. benthamiana* leaves ([Figure 4](#gkt152-F4){ref-type="fig"}). The S-PTGS components RDR6 and SGS3 were confirmed to localize in cytoplasmic foci. We also confirmed the previously reported subcellular localization of UPF3 and UPF1 in the nucleus and cytoplasmic foci, respectively ([@gkt152-B77],[@gkt152-B78]). RRP44A was previously reported to be predominantly nuclear ([@gkt152-B35]), and we observed that the core subunits of the exosome, RRP4 and RRP41, also were detected primarily in the nucleus, with only a weak diffuse signal present in the cytoplasm ([Figure 4](#gkt152-F4){ref-type="fig"}). Finally, we showed that the deadenylation factors CCR4a and PARN both accumulated in cytoplasmic foci ([Figure 4](#gkt152-F4){ref-type="fig"}). The subcellular localizations of UPF3, RRP41, CCR4a, PARN, RDR6 and SGS3 observed in transient expression were confirmed in stable *Arabidopsis* lines expressing the fusion proteins at low levels ([Supplementary Figure S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)), indicating that the subcellular localizations observed in *N. benthamiana* leaves are not artifacts caused by over-expression. Figure 4.Subcellular localization of NMD, deadenylation, exosome and PTGS components. Confocal sections and their corresponding bright-field images of *N. benthamiana* leaves expressing the indicated proteins fused to GFP. The arrowheads indicate cytoplasmic foci, whereas 'n' labels the nucleus. Scale bars are shown on the images.

Although RDR6 has been reported in both the nucleus and the cytoplasm, it only co-localizes with SGS3 in cytoplasmic foci called siRNA-bodies ([@gkt152-B75],[@gkt152-B79; @gkt152-B80; @gkt152-B81]). Another class of cytoplasmic foci involved in mRNA degradation, distinct from siRNA-bodies, is the P-bodies where the decapping complex protein DCP1 accumulates ([@gkt152-B29],[@gkt152-B80]). We therefore investigated whether the cytoplasmic foci observed for UPF1, PARN and CCR4a were siRNA-bodies or P-bodies or these proteins shuttle between them. To this end, we co-expressed these tagged proteins with either fluorescently tagged DCP1 or SGS3. We observed that tagged UPF1, PARN and CCR4a co-localized with both DCP1 and SGS3 ([Figure 5](#gkt152-F5){ref-type="fig"}A and B). Quantification of the proportion of UPF1, PARN and CCR4a bodies co-localizing with DCP1 (P-bodies) or SGS3 (siRNA-bodies) indicated that while nearly 70% of PARN foci co-localized with siRNA-bodies and \>60% of CCR4a foci were associated with P-bodies ([Figure 5](#gkt152-F5){ref-type="fig"}A--C), UPF1 was found nearly equally associated with both siRNA- and P-bodies. The fraction of UPF1 that co-localized with P- or siRNA-bodies nearly equaled the fraction of UPF1 that was non-co-localized to the other body (siRNA- or P-bodies, respectively, [Figure 5](#gkt152-F5){ref-type="fig"}C); thus, we more precisely examine these associations through a triple localization experiment among UPF1, DCP1 and SGS3. In the triple localization, we examined 32 adjacent P- and siRNA-body clusters and observed that for a given group of closely associated P- and siRNA-bodies, the UPF1 protein was either associated with the P-body or the siRNA-body but never with both bodies in the same cluster at the same time ([Figure 5](#gkt152-F5){ref-type="fig"}D and [Supplementary Table S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt152/-/DC1)). Figure 5.UPF1, PARN and CCR4a associate with both P- and siRNA-bodies. (**A** and **B**) Confocal sections of *N. benthamiana* leaves co-expressing the indicated fluorescent fusion proteins. Co-expression of UPF1, PARN and CCR4a with DCP1, a P-bodies marker (A), or with SGS3, a siRNA-bodies marker (B). White arrowheads indicate co-localization, and open arrowheads indicate foci positive for only one of the two fusion proteins. The area enclosed in the dashed box is shown in the close-up view. (**C**) Percentage of UPF1, PARN and CCR4a foci that co-localize with either P-bodies (as marked by DCP1) or siRNA-bodies (as marked by SGS3). Percentage of foci co-localizing (black) or not co-localizing (grey) with DCP1 and SGS3. The total number of foci counted is indicated above each bar. DCP1 and SGS3 foci were never observed to overlap. (**D**) Confocal sections of *N. benthamiana* leaves co-expressing SGS3, DCP1 and UPF1 fluorescent fusion proteins. Upper row: UPF1 is associated with a siRNA-body that is located adjacent to a P-body. Lower row: UPF1 is associated with a P-body that is located adjacent to two siRNA-bodies. The area enclosed in the dashed box is shown in the close-up view. Scale bars are shown on the images.

DISCUSSION
==========

Our results hint to a multi-layered regulatory network governing RQC and PTGS in different subcellular compartments. It was shown previously that mutations in the cytoplasmic exoribonuclease XRN4, the cytoplasmic decapping component DCP2 and the nuclear exoribonuclease XRN2 and XRN3 enhance PTGS ([@gkt152-B49],[@gkt152-B82]). Here, we show that, in addition to mutations in several cytoplasmic deadenylation and NMD components, mutations in essentially nuclear RQC components (UPF3, RRP44A and RRP6L1) enhance PTGS. These results are in agreement with the existence of both a cytoplasmic and a nuclear arm to the PTGS pathway ([@gkt152-B79],[@gkt152-B83],[@gkt152-B84]) and suggest that nuclear RNAs, in addition to cytoplasmic RNAs, are instrumental during S-PTGS. However, it remains unknown if these nuclear localized proteins are spatially associated with nuclear components of PTGS. Indeed, the DCL proteins responsible for siRNA generation are nuclear localized ([@gkt152-B85]). Additional work is needed to examine these putative associations.

Although it is intriguing to imagine a nuclear interface among these pathways, we cannot exclude the possibility that RNA substrates that evade elimination by these nuclear RQC components are exported from the nucleus where they trigger S-PTGS in the cytoplasm. Moreover, it is also possible that at least a fraction of these primarily nuclear RQC proteins can be shuttled to the cytoplasm at certain times. Indeed, in yeast, UPF3 is shuttle protein operating in NMD, which involves both nuclear-localized steps and a cytoplasmic-localized translation termination coupled step ([@gkt152-B86]).

Our observations that UPF1, CCR4a and PARN co-localize with both P- and siRNA-body markers suggest that exchange of ribonucleoparticle substrates between the two RNA degradation bodies can occur. We propose a model of ssRNA tug-of-war between RQC and S-PTGS that ensures the correct partitioning of aberrant RNA substrates among these RNA degradation mechanisms, potentially contributing to the discrimination of dysfunctional self-RNA and invading non--self-RNA from functional self-RNA ([@gkt152-B87]). We assert that this discrimination allows a cell to efficiently clear undesirable RNAs without triggering PTGS, which, owing to the amplification of siRNA production, would lead to the unregulated trans-degradation of any RNA transcripts sharing homology with the dsRNA trigger. Indeed, it is interesting to speculate that the existence of the S-PTGS pathway may serve to reinforce the efficiency of RQC pathways to eliminate defective RNAs.

We recognize that this system of checks and balances between PTGS and RQC pathways was revealed in RQC mutant plants, and, thus, contend that these pathways may normally act independently, and that RNA substrate sharing may only occur when RQC pathways are rendered inefficient or compromised. Indeed, it is highly plausible that, in normal conditions, defective endogenous transcripts are eliminated efficiently by RQC pathways so as to prevent their 'auto-death' by PTGS.
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